INTERCEPT PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Intercept Pharmaceuticals, Inc. quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q3 2022.
  • Intercept Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-01
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q1 2016 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.